Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the ...
With lower global beef exports and pork trade facing regional constraints, poultry stands to gain as a flexible, ...
ViGenCell Inc. (KOSDAQ: 308080), a clinical-stage biotechnology company based in South Korea focused on advanced cell therapies, today announced that results from its Phase 2 clinical study of ...
Fifty state college and university employees were mailed corrected tax forms on the afternoon of April 15 — the very day they ...
A Navy-engineered cybersecurity system infused with APL innovation, called Situational Awareness, Boundary Enforcement, and ...
With the FIFA World Cup coming to the area this summer, Mountain View is looking to boost the liveliness of its downtown area ...
The numbers are the first to quantify the effect of the Trump administration’s shutdown and restarting of a program that has ...
Hospital and pharma groups have sharpened their spears for the rematch on 340B rebates. | The administration's second stab ...
Explore the UFO mysteries J. Allen Hynek uncovered with Project Blue Book and how his findings challenged the Air Force's ...
An investigational cocktail was tied to a 0% overall response rate in patients with gastroesophageal cancer, but developers ...
Longer export licensing timelines last year imposed measurable costs on U.S. firms, including lost contracts, reputational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results